A lesser known cannabis component known as CBG could represent a novel treatment in the treatment of rheumatoid arthritis (RA), according to a new study. Researchers…
Two non-psychoactive cannabis compounds, cannabidiol (CBD) and cannabigerol (CBG), could offer new treatment options for metabolic dysfunction-associated steatotic liver disease (MASLD), according to research published in…